In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer

References

• Ad VDA. (2008). The lessons of GIST–PET and PET/CT: a new paradigm for imaging. Oncologist 13: 8–13.
   PubMed Web of Science ®Google Scholar
• Arshad A , Yang B , Bienemann AS , et al . (2015). Convection-enhanced delivery of carboplatin PLGA nanoparticles for the treatment of glioblastoma. PLos One 10:e0132266. doi: 10.1371/journal.pone.0132266
   PubMed Web of Science ®Google Scholar
• Aukema TS , Kappers I , Olmos RA. et al. (2010). Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer?. J Nucl Med 51:1344–8.
   PubMed Web of Science ®Google Scholar
• Azzoli CG , Giaccone G , Temin S. (2010). American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer. JOP 6:39–43.
   PubMedGoogle Scholar
• Bartoš V , Adamicová K , Kullová M , et al . (2012). Evaluation of proliferative activity (Ki-67 index) in different histological types of cutaneous basal cell carcinoma. Biologia 67:610–15.
   Web of Science ®Google Scholar
• Bergman E , Forsell P , Persson EM , et al . (2007). Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors. Int J Pharm 341:134–42.
   PubMed Web of Science ®Google Scholar
• Burgess DJ. (2011). Cancer genetics: Initially complex, always heterogeneous. Nat Rev Genet 12:154–5.
   PubMed Web of Science ®Google Scholar
• Chokshi RJ , Zia H , Sandhu HK , et al . (2007). Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons. Drug Deliv 14:33.
   PubMed Web of Science ®Google Scholar
• De SR , Zahedi P , Allen CJ , Piquette-Miller M. (2010). Polymeric drug delivery systems for localized cancer chemotherapy. Drug Deliv 17:365–75.
   PubMed Web of Science ®Google Scholar
• Denizot F , Lang RJ. (1986). Rapid colorimetric assay for cell growth and survival, modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271–7.
   PubMed Web of Science ®Google Scholar
• Fang J , Liao L , Yin H , et al . (2014). Enhanced bacterial tumor delivery by modulating the EPR effect and therapeutic potential of Lactobacillus casei. J Pharm Sci 103:3235–43.
   PubMed Web of Science ®Google Scholar
• Guo G , Fu S , Zhou L , et al . (2011). Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells. Nanoscale 3:3825.
   PubMed Web of Science ®Google Scholar
• Hachemi M , Couturier C , Vervueren L , et al. (2013). [18F]FDG positron emission tomography within two weeks of starting erlotinib therapy can predict response in non-small cell lung cancer patients. PLos One 9:p. e87629.
   Web of Science ®Google Scholar
• Herbst RS , Heymach JV , Lippman SM. (2008). Lung cancer. N Engl J Med 359:1367–80.
   PubMed Web of Science ®Google Scholar
• Hsu TI , Wang YC , Hung CY , et al . (2016). Positive feedback regulation between IL10 and EGFR promotes lung cancer formation. Oncotarget 7:20840–54.
   PubMed Web of Science ®Google Scholar
• Jacob F , Yonis AY , Cuello F , et al . (2016). Analysis of tyrosine kinase inhibitor-mediated decline in contractile force in rat engineered heart tissue. PLos One 11:e0145937.
   PubMed Web of Science ®Google Scholar
• Jia W , Gu Y , Gou M , et al . (2008). Preparation of biodegradable polycaprolactone/poly (ethylene glycol)/polycaprolactone (PCEC) nanoparticles. Drug Deliv 15:409–16.
   PubMed Web of Science ®Google Scholar
• Lam AT , Yoon J , Ganbold E , et al . (2014). Colloidal gold nanoparticle conjugates of gefitinib. Colloids Surf B Biointerfaces 123:61–7.
   PubMed Web of Science ®Google Scholar
• Lee YC. (2013). Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells. Oncol Rep 29:237.
   PubMed Web of Science ®Google Scholar
• Lee YHP , Sathigari S , Lin YJ , et al . (2009). Gefitinib–cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Drug Dev Ind Pharm 35:1113–20.
   PubMed Web of Science ®Google Scholar
• Li L , Huang W , Li K , et al . (2015). Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway. Oncotarget 6:43605–19.
   PubMed Web of Science ®Google Scholar
• Maemondo M , Inoue A , Kobayashi K , et al . (2010). Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362:2380–8.
   PubMed Web of Science ®Google Scholar
• Mora-Huertas CE , Fessi H , Elaissari A. (2010). Polymer-based nanocapsules for drug delivery. Int J Pharm 385:113.
   PubMed Web of Science ®Google Scholar
• Muntimadugu E , Kumar R , Saladi S , et al . (2016). CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Colloids Surf B Biointerfaces 143:532–46.
   PubMed Web of Science ®Google Scholar
• Natarajan JV , Nugraha C , Ng XW , Venkatraman S. (2014). Sustained-release from nanocarriers: a review. J Control Release 193:122–38.
   PubMed Web of Science ®Google Scholar
• Nefedova NA , Kharlova OA , Danilova NV , et al . (2016). Markers of angiogenesis in tumor growth. Arkh Patol 78:55.
   PubMedGoogle Scholar
• Pastore S , Mascia F , Mariani V , Girolomoni G , et al . (2008). The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 128:1365–74.
   PubMed Web of Science ®Google Scholar
• Rahman AFMM , Korashy HM , Kassem MG. (2014). Chapter five–gefitinib . Profiles Drug Subst Excip Relat Methodol 39:239–264.
   Google Scholar
• Shi Y. (2014). Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells. J Nanobiotechnol 12:43.
   PubMed Web of Science ®Google Scholar
• Shintani S , Kleeff J , Giese N , et al . (2004). Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines. Oral Oncol 40:43–51.
   PubMed Web of Science ®Google Scholar
• Soria M , Venugopal K , Saha RN , et al . (2008). Etoposide-loaded PLGA and PCL nanoparticles I: preparation and effect of formulation variables. Drug Deliv 15:267–75.
   Web of Science ®Google Scholar
• Suciu BA , Mezei T , Pap X , et al . (2015). Evaluation of tumor angiogenesis in patients with non-small cell lung carcinoma. Ars Medica Tomitana 21:81–6.
   Google Scholar
• Takeda M , Nakagawa K. (2015). Role of EGFR monoclonal antibodies in the management of non-small cell lung cancer. Curr Cancer Drug Targets 15:792.
   PubMed Web of Science ®Google Scholar
• Trummer BJ , Iyer V , Balu-Iyer SV , O'Connor R , et al . (2012). Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinib. J Pharm Sci 101:2763–76.
   PubMed Web of Science ®Google Scholar
• Warburton D , Shi W , Xu B. (2012). TGF-β-Smad3 signaling in emphysema and pulmonary fibrosis: an epigenetic aberration of normal development?. Am J Physiol Lung Cell Mol Physiol 304:83–5.
   Web of Science ®Google Scholar
• Wilson CG , O’Mahonya B, Connollya SM, et al. (2009). Do gastrointestinal transit parameters influence the pharmacokinetics of gefitinib? Int J Pharm 376:7–12.
   PubMed Web of Science ®Google Scholar
• Yadav AK , Agarwal A , Rai G , et al . (2010). Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Drug Deliv 17:561–72.
   PubMed Web of Science ®Google Scholar
• Yang B , Ni X , Chen L , et al . (2017). Honokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinoma. Drug Deliv 24:660.
   PubMed Web of Science ®Google Scholar
• Zhao L , Yang G , Shi Y , et al . (2015). Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance. J Nanobiotechnol 13:1–10.
   PubMed Web of Science ®Google Scholar